Serina Therapeutics (SER) announced that Randall Moreadith, CDO, will present new data at the ACS Spring 2025 Meeting and Expo in San Diego, CA. His presentation, titled “A Non-Immunogenic LNP ...

March 25, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ®, Inc. (Nasdaq ... it will present data at the National Kidney Foundation Spring Clinical Meetings 2025 (NKF SCM25), which will take ...

SpringWorks Therapeutics, Inc. has a one year low of $28.21 and a one year high of $62.00. The company has a fifty day moving average price of $47.22 and a 200 day moving average price of $39.58.

Six new murals will be soon be a colorful addition to Springfield Avenue — turning six utility boxes into creative outdoor ...

HUNTSVILLE, AL, March 24, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics ... will present new data at the ACS Spring 2025 Meeting and Expo in San Diego, CA. His presentation, titled "A Non ...

In other SpringWorks Therapeutics news, insider Daniel Pichl sold 29,750 shares of the stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $54.36, for a ...

Akebia Therapeutics, Inc. announced that it will present data at the National Kidney Foundation Spring Clinical Meetings 2025 (NKF SCM25) in Boston from April 10-13, 2025. The company will display ...

Serina Therapeutics, Inc., a clinical-stage biotechnology company, announced that Dr. Randall Moreadith, Chief Development Officer, will present findings at the ACS Spring 2025 Meeting in San ...

Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it will present data at the ...